The AAMC and Thalamus are collaborating to accelerate innovation across the transition to residency process.

Through this collaboration, all residency and fellowship programs receive complimentary access to the Thalamus interview management platform, Thalamus Core and Itinerary Wizard, as well as Cerebellum, a novel data and analytics dashboard to assess recruitment outcomes, specifically from a diversity, equity, inclusion, and geographic perspective. Programs may also elect to purchase Thalamus’ video interview platform and Cortex, its technology-assisted holistic application review and screening platform. 

Beyond these immediate benefits, the AAMC and Thalamus will collaborate to leverage their data, technology, and expertise to transform the medical residency and fellowship recruitment processes for applicants and programs by increasing transparency, supporting equity through holistic review, and improving the learner experience by consolidating the fragmented interview management process. 

Learn more about the positive impact of this collaboration.

Next Steps for Residency and Fellowship Programs

All ERAS programs can take advantage of these expanded capabilities by completing a sign-up form to express interest in selected Thalamus products. If you are a Designated Institutional Official (DIOs) or other GME executive expressing interest for your entire institution, please use the form for institutions. Otherwise, please use the form for programs. Within a few business days, a member of the Thalamus team will reach out to share more information and discuss next steps. Questions about signing up? Please contact Thalamus at

View Press Release | View FAQs

Products Available to the ERAS Community

* Thalamus Core, Itinerary Wizard, and Cerebellum are available at no cost to ERAS programs. Programs may also elect to purchase Thalamus’ video interview platform and Cortex.

About Collaborating Organizations

About the Association of American Medical Colleges

The AAMC (Association of American Medical Colleges) is a nonprofit association dedicated to improving the health of people everywhere through medical education, health care, medical research, and community collaborations. Its members are all 157 U.S. medical schools accredited by the Liaison Committee on Medical Education; 13 accredited Canadian medical schools; approximately 400 teaching hospitals and health systems, including Department of Veterans Affairs medical centers; and more than 70 academic societies. Through these institutions and organizations, the AAMC leads and serves America’s medical schools and teaching hospitals and the millions of individuals across academic medicine, including more than 193,000 full-time faculty members, 96,000 medical students, 153,000 resident physicians, and 60,000 graduate students and postdoctoral researchers in the biomedical sciences. Following a 2022 merger, the Alliance of Academic Health Centers and the Alliance of Academic Health Centers International broadened the AAMC’s U.S. membership and expanded its reach to international academic health centers. Visit the AAMC.

About Thalamus

Thalamus is the premier, cloud-based interview management platform designed specifically for application to Graduate Medical Education (GME) training programs. The software streamlines communication by eliminating unnecessary phone calls/emails allowing applicants to book interviews in real-time, while acting as a comprehensive applicant tracking system for residency and fellowship programs. Thalamus provides comprehensive online interview scheduling and travel coordination via a real-time scheduling system, video interview platform, AI application screening/review tool (Cortex) providing technology-assisted holistic review, and first-in-class DEI-focused analytics dashboard (Cerebellum). Featured nationally at over 300+ institutions and used by >90% of applicants, Thalamus is the most comprehensive solution in GME interview management. For more information on Thalamus, please visit or connect with us on LinkedIn, Facebook, Instagram, Twitter or YouTube.